Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework
- PMID: 27430274
- PMCID: PMC5038058
- DOI: 10.1128/IAI.00469-16
Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework
Abstract
Historically, the nature and extent of host damage by a microbe were considered highly dependent on virulence attributes of the microbe. However, it has become clear that disease is a complex outcome which can arise because of pathogen-mediated damage, host-mediated damage, or both, with active participation from the host microbiota. This awareness led to the formulation of the damage response framework (DRF), a revolutionary concept that defined microbial virulence as a function of host immunity. The DRF outlines six classifications of host damage outcomes based on the microbe and the strength of the immune response. In this review, we revisit this concept from the perspective of Candida albicans, a microbial pathogen uniquely adapted to its human host. This fungus commonly colonizes various anatomical sites without causing notable damage. However, depending on environmental conditions, a diverse array of diseases may occur, ranging from mucosal to invasive systemic infections resulting in microbe-mediated and/or host-mediated damage. Remarkably, C. albicans infections can fit into all six DRF classifications, depending on the anatomical site and associated host immune response. Here, we highlight some of these diverse and site-specific diseases and how they fit the DRF classifications, and we describe the animal models available to uncover pathogenic mechanisms and related host immune responses.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
Figures
Similar articles
-
Applying the Host-Microbe Damage Response Framework to Candida Pathogenesis: Current and Prospective Strategies to Reduce Damage.J Fungi (Basel). 2020 Mar 11;6(1):35. doi: 10.3390/jof6010035. J Fungi (Basel). 2020. PMID: 32168864 Free PMC article. Review.
-
Looking into Candida albicans infection, host response, and antifungal strategies.Virulence. 2015;6(4):307-8. doi: 10.1080/21505594.2014.1000752. Epub 2015 Jan 15. Virulence. 2015. PMID: 25590793 Free PMC article.
-
Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.J Microbiol. 2016 Mar;54(3):149-69. doi: 10.1007/s12275-016-5514-0. Epub 2016 Feb 27. J Microbiol. 2016. PMID: 26920876 Review.
-
Proteomic profiling of serologic response to Candida albicans during host-commensal and host-pathogen interactions.Methods Mol Biol. 2009;470:369-411. doi: 10.1007/978-1-59745-204-5_26. Methods Mol Biol. 2009. PMID: 19089396
-
Dissecting Candida albicans Infection from the Perspective of C. albicans Virulence and Omics Approaches on Host-Pathogen Interaction: A Review.Int J Mol Sci. 2016 Oct 18;17(10):1643. doi: 10.3390/ijms17101643. Int J Mol Sci. 2016. PMID: 27763544 Free PMC article. Review.
Cited by
-
Development of Novel Amphotericin B-Immobilized Nitric Oxide-Releasing Platform for the Prevention of Broad-Spectrum Infections and Thrombosis.ACS Appl Mater Interfaces. 2021 May 5;13(17):19613-19624. doi: 10.1021/acsami.1c01330. Epub 2021 Apr 27. ACS Appl Mater Interfaces. 2021. PMID: 33904311 Free PMC article.
-
Candida albicans-A systematic review to inform the World Health Organization Fungal Priority Pathogens List.Med Mycol. 2024 Jun 27;62(6):myae045. doi: 10.1093/mmy/myae045. Med Mycol. 2024. PMID: 38935906 Free PMC article.
-
Filamentation and biofilm formation are regulated by the phase-separation capacity of network transcription factors in Candida albicans.PLoS Pathog. 2023 Dec 13;19(12):e1011833. doi: 10.1371/journal.ppat.1011833. eCollection 2023 Dec. PLoS Pathog. 2023. PMID: 38091321 Free PMC article.
-
Bio- and Nanotechnology as the Key for Clinical Application of Salivary Peptide Histatin: A Necessary Advance.Microorganisms. 2020 Jul 10;8(7):1024. doi: 10.3390/microorganisms8071024. Microorganisms. 2020. PMID: 32664360 Free PMC article. Review.
-
Candida albicans rvs161Δ and rvs167Δ Endocytosis Mutants Are Defective in Invasion into the Oral Cavity.mBio. 2019 Nov 12;10(6):e02503-19. doi: 10.1128/mBio.02503-19. mBio. 2019. PMID: 31719181 Free PMC article.
References
-
- Calderone RA. 2012. Candida and candidiasis. ASM Press, Washington, DC.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical